Showing 371-380 of 8354 results for "".
A Non-Invasive 2-Gene Molecular Assay Shows Promise in Assessment of Pigmented Lesions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-non-invasive-2-gene-molecular-assay-shows-promise-in-assessment-of-pigmented-lesions/20705/More studies are needed, but a non-invasive assay that identified melanoma gene expression could support clinical decision making.Skin Cancer Prevention, Mohs Data, Allergan Closes on Zeltiq
https://practicaldermatology.com/topics/practice-management/dermwiretv-skin-cancer-prevention-mohs-data-allergan-closes-on-zeltiq/18479/It's Skin Cancer Awareness Month. Joel L. Cohen, MD and Shadi Kourosh, MD share tips on patient education and skin protection. Plus, new data set the stage for developing best practices for Mohs micrographic surgery. Wendy Lewis offers tips for digital marketing success. Plus, Allergan closes the deThe Male Aesthetic Patient: Who He Is and What He Needs
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-male-aesthetic-patient-who-he-is-and-what-he-needs/18701/Baby boomer men aren't necessarily driving the growth in male aesthetics. Terrence Keaney, MD says that millennial men in their 30s and 40s are most likely to seek treatments. In the initial consultation, education is essential so men understand the treatments offered and recognize that you understaWhat Do You Expect?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/what-do-you-expect/18751/By Emmy Graber, MD and Seemal R. Desai, MDDo you always show prospective patients your best photos? Sometimes it's good to show the average result. Dr. Graber discusses this and other aspects of expectation management for cosmetic interventions.Cellfina Cleared, Finacea Foam Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-cellfina-cleared-finacea-foam-approved/18866/The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 years. Finacea Foam (azelaic acid, Bayer Dermatology) is approved for Rosacea, and Almirall invests in Suneva Medical, maker of Bellafill. Also in this edition, a look at the data oNon-invasive “Mega” Laser Combinations: How to Achieve Maximal Results
https://practicaldermatology.com/topics/practice-management/non-invasive-mega-laser-combinations-how-to-achieve-maximal-results/21150/Improved outcomes and shortened downtime are just some of the advantages of multi-modality approaches to the evolving non-invasive aesthetic front.Advocacy Groups and Physicians: The New Power Couple
https://practicaldermatology.com/topics/practice-management/advocacy-groups-and-physicians-the-new-power-couple/21191/Patient advocacy organizations partnering with dermatology physician-scientists offer an exciting new model for optimized patient care.Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.Preserve the Core; Live Your Aesthetic
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/preserve-the-core-live-your-aesthetic/19083/Heidi Waldorf, MD, FAAD and Steven Dayan, MD, FACS, Co-Chief Medical Editors of Modern Aesthetics®magazine, talk about the importance of staying true to your aesthetic and address the challenges of preserving the core specialties.Antioxidants and Sunscreens
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-sunscreens--esapeged/19091/Jennifer Linder, MD, FAAD explains the science behind antioxidants in sunscreens and discusses the benefits of using antioxidants along with SPF.